Cargando…

The Reversed Feto-Maternal Bile Acid Gradient in Intrahepatic Cholestasis of Pregnancy Is Corrected by Ursodeoxycholic Acid

Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-specific liver disorder associated with an increased risk of adverse fetal outcomes. It is characterised by raised maternal serum bile acids, which are believed to cause the adverse outcomes. ICP is commonly treated with ursodeoxycholic acid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geenes, Victoria, Lövgren-Sandblom, Anita, Benthin, Lisbet, Lawrance, Dominic, Chambers, Jenny, Gurung, Vinita, Thornton, Jim, Chappell, Lucy, Khan, Erum, Dixon, Peter, Marschall, Hanns-Ulrich, Williamson, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885440/ https://www.ncbi.nlm.nih.gov/pubmed/24421907 http://dx.doi.org/10.1371/journal.pone.0083828

Ejemplares similares

Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study
por: Manna, LB, et al.
Publicado: (2019)

Feto-Maternal Effects of Adding Rifampicin to Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy
por: Kumari, Anjali, et al.
Publicado: (2022)

Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis
por: Gurung, Vinita, et al.
Publicado: (2009)

Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial
por: Chappell, Lucy C, et al.
Publicado: (2012)

Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations
por: Vasavan, Tharni, et al.
Publicado: (2021)

Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial
por: Fleminger, J, et al.
Publicado: (2020)

Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial
por: Chappell, Lucy C, et al.
Publicado: (2019)

Ursodeoxycholic acid improves feto-placental and offspring metabolic outcomes in hypercholanemic pregnancy
por: Borges Manna, Luiza, et al.
Publicado: (2020)

Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis
por: Ovadia, Caroline, et al.
Publicado: (2021)

Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid
por: Joutsiniemi, Titta, et al.
Publicado: (2015)

Ursodeoxycholic Acid and S-adenosylmethionine for the Treatment of Intrahepatic Cholestasis of Pregnancy: A Meta-analysis
por: Zhang, Yang, et al.
Publicado: (2016)

Effect of polyene phosphatidylcholine/ursodeoxycholic acid/ademetionine on pregnancy outcomes in intrahepatic cholestasis
por: Dong, Xiao-Rui, et al.
Publicado: (2023)

Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES)
por: Chappell, Lucy C., et al.
Publicado: (2018)

Bile Acids in Intrahepatic Cholestasis of Pregnancy
por: Majsterek, Maciej, et al.
Publicado: (2022)

Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum
por: Abu‐Hayyeh, Shadi, et al.
Publicado: (2015)

Intrahepatic Cholestasis of Pregnancy Levels of Sulfated Progesterone Metabolites Inhibit Farnesoid X Receptor Resulting in a Cholestatic Phenotype
por: Abu-Hayyeh, Shadi, et al.
Publicado: (2013)

A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trial
por: Hague, William M., et al.
Publicado: (2021)

Influence of ursodeoxycholic acid therapy on levels of fibroblast growth factor 21, adiponectin and biochemical parameters in intrahepatic cholestasis of pregnancy
por: Kukla, Michał, et al.
Publicado: (2021)

Association of Severe Intrahepatic Cholestasis of Pregnancy With Adverse Pregnancy Outcomes: A Prospective Population-Based Case-Control Study
por: Geenes, Victoria, et al.
Publicado: (2014)

Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study)
por: Kong, Xiang, et al.
Publicado: (2016)

CT Image Features under Reconstruction Algorithm in Analysis of the Effect of Probiotics Combined with Ursodeoxycholic Acid in Treatment of Intrahepatic Cholestasis of Pregnancy
por: Liu, Hongxue, et al.
Publicado: (2021)

Ursodeoxycholic acid improves pregnancy outcome in patients with intrahepatic cholestasis during pregnancy: A protocol for systematic review and meta-analysis
por: Wang, Yan, et al.
Publicado: (2021)

Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit
por: Lewis, Tamorah, et al.
Publicado: (2018)

The effects of ursodeoxycholic acid on sepsis-induced cholestasis management in an animal model
por: Ainosah, Randa H., et al.
Publicado: (2020)

Ursodeoxycholic Acid and SMOFlipid for Treating Parenteral Nutrition Associated Cholestasis in Infants
por: Al-Alaiyan, Saleh, et al.
Publicado: (2022)

Placental Expression of Bile Acid Transporters in Intrahepatic Cholestasis of Pregnancy
por: Ontsouka, Edgar, et al.
Publicado: (2021)

High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy
por: Azzaroli, Francesco, et al.
Publicado: (2013)

Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study): Erratum
Publicado: (2017)

Paternal cholestasis exacerbates obesity-associated hypertension in male offspring but is prevented by paternal ursodeoxycholic acid treatment
por: Pataia, Vanessa, et al.
Publicado: (2018)

A Comprehensive Analysis of Common Genetic Variation Around Six Candidate Loci for Intrahepatic Cholestasis of Pregnancy
por: Dixon, Peter H, et al.
Publicado: (2014)

Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
por: Mueller, Michaela, et al.
Publicado: (2015)

Maternal bile acid profile and subtype analysis of intrahepatic cholestasis of pregnancy
por: Shao, Yong, et al.
Publicado: (2021)

Efficacy and safety of ursodeoxycholic acid in children with cholestasis: A systematic review and meta-analysis
por: Huang, Liang, et al.
Publicado: (2023)

Intrahepatic Cholestasis of Pregnancy and Serum Bile Acids in HIV-Infected Pregnant Women
por: Weinberg, Adriana, et al.
Publicado: (2015)

Effect of Bile Acid on Fetal Lung in Rat Model of Intrahepatic Cholestasis of Pregnancy
por: Yu, Ling, et al.
Publicado: (2014)

Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis
por: Gomez-Ospina, Natalia, et al.
Publicado: (2016)

Targeted metabolomics of sulfated bile acids in urine for the diagnosis and grading of intrahepatic cholestasis of pregnancy
por: Li, Yuchao, et al.
Publicado: (2018)

Intrahepatic cholestasis of pregnancy: Relationship between bile acid levels and maternal and fetal complications
por: Çetinkaya Demir, Bilge, et al.
Publicado: (2014)

Intrahepatic Cholestasis of Pregnancy: Role of Baby’s Sex on Itch Severity and Bile Acid Levels
por: Bartolone, Samantha, et al.
Publicado: (2021)

Gut microbiota alters host bile acid metabolism to contribute to intrahepatic cholestasis of pregnancy
por: Tang, Bo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k9lv766vqh1ei55cb6pdqr0sq6